Skip to main content
Caplight Logo









MRM Health

MRM Health

Private
BelgiumHealthcare & Life Scienceshttps://mrmhealth.com/

Last Round

Grant

May 28, 2026

Total Funding Raised

$82.16M

Company Overview

MRM Health is a clinical-stage biopharmaceutical company that develops innovative microbiome-based live biotherapeutic products for the treatment of chronic inflammatory diseases and immune-oncology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

microbiome therapeuticslive biotherapeutic productsLBPmicrobiome drugbacterial consortiaulcerative colitisgut microbiomeIBDinflammatory bowel diseasemetabolic diseasedrug discoverybiotechgut healthclinical-stage biotechbioinformatics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MRM Health Comparables

Compare MRM Health with similar companies based on industry and business-model similarity.

MRM Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PharmaBiome
84%
Vedanta Biosciences
83%
Microbiotica
82%

MRM Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 28, 2026
Series BSep 4, 2025
Series AFeb 19, 2020

Key People

Founding team and executive leadership

Sam Possemiers

Chief Executive Officer

Executive Team

Jan Binon

Interim CFO

Executive Team

MRM Health Investors

Notable investors and investment history

MRM Health investors
InvestorRounds
Federal Holding and Investment CompanySeries B
Ackermans & van HaarenSeries B, Series A
Athos KGSeries B
Qbic IISeries A, Series B
BNP Paribas Fortis Private EquitySeries B
BiocodexSeries B
VIBSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 9, 2026

    IND clearance granted for Phase 2b trial of MH002 for ulcerative colitis.

  • Jan 5, 2026

    Presenting at Digestive Disease Week (DDW) 2026 in Chicago.

MRM Health Filings

Explore SEC and related filing metadata, where available.

MRM Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MRM Health's valuation, stock price, and market status.

Is MRM Health a public or private company?

MRM Health is a private company.

What is the current stock price of MRM Health?

MRM Health is a private company with no public stock price. No recent secondary market data is available.

How much is MRM Health worth (valuation)?

Valuation information for MRM Health is not publicly available.

Can I buy MRM Health stock?

MRM Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MRM Health's last funding round?

MRM Health's most recent funding round was Series B on September 4, 2025.

Who are the main investors in MRM Health?

Key investors in MRM Health include Ackermans & van Haaren, Biocodex.

Will MRM Health IPO soon?

No public IPO plans have been announced for MRM Health.

How can I track MRM Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MRM Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBelgium
Employee Range31
Year Founded2020
Last FundingMay 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?